US5559094A
(en)
*
|
1994-08-02 |
1996-09-24 |
Eli Lilly And Company |
AspB1 insulin analogs
|
US6251856B1
(en)
|
1995-03-17 |
2001-06-26 |
Novo Nordisk A/S |
Insulin derivatives
|
HUP9800523A3
(en)
*
|
1995-03-17 |
1998-09-28 |
Novo Nordisk As |
Insulin derivatives
|
DE19726167B4
(de)
|
1997-06-20 |
2008-01-24 |
Sanofi-Aventis Deutschland Gmbh |
Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
|
US7638618B2
(en)
|
2001-02-20 |
2009-12-29 |
Sanofi-Aventis Deutschland Gmbh |
Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest
|
US7202059B2
(en)
|
2001-02-20 |
2007-04-10 |
Sanofi-Aventis Deutschland Gmbh |
Fusion proteins capable of being secreted into a fermentation medium
|
DE10114178A1
(de)
|
2001-03-23 |
2002-10-10 |
Aventis Pharma Gmbh |
Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
|
DE10227232A1
(de)
|
2002-06-18 |
2004-01-15 |
Aventis Pharma Deutschland Gmbh |
Saure Insulinzubereitungen mit verbesserter Stabilität
|
ES2642214T3
(es)
|
2004-01-21 |
2017-11-15 |
Novo Nordisk Health Care Ag |
Conjugación de péptidos mediante transglutaminasa
|
JP5550338B2
(ja)
|
2006-07-31 |
2014-07-16 |
ノボ・ノルデイスク・エー/エス |
ペグ化持続型インスリン
|
US9018161B2
(en)
|
2006-09-22 |
2015-04-28 |
Novo Nordisk A/S |
Protease resistant insulin analogues
|
JP5496082B2
(ja)
|
2007-04-30 |
2014-05-21 |
ノボ・ノルデイスク・エー/エス |
タンパク質組成物を乾燥させる方法、乾燥タンパク質組成物、及び乾燥タンパク質を含有する薬学的組成物
|
RU2524423C2
(ru)
|
2008-01-09 |
2014-07-27 |
Санофи-Авентис Дойчланд Гмбх |
Новые производные инсулина с чрезвычайно замедленным профилем время/действие
|
WO2009112583A2
(en)
|
2008-03-14 |
2009-09-17 |
Novo Nordisk A/S |
Protease-stabilized insulin analogues
|
PL2254906T3
(pl)
|
2008-03-18 |
2017-04-28 |
Novo Nordisk A/S |
Stabilizowane względem proteaz, acylowane analogi insuliny
|
CA2740685C
(en)
|
2008-10-17 |
2018-09-11 |
Sanofi-Aventis Deutschland Gmbh |
Combination of an insulin and a glp-1 agonist
|
DE102008051834A1
(de)
|
2008-10-17 |
2010-04-22 |
Sanofi-Aventis Deutschland Gmbh |
Kombination von einem Insulin und einem GLP-1-Agonisten
|
DE102009038210A1
(de)
|
2009-08-20 |
2011-03-03 |
Sanofi-Aventis Deutschland Gmbh |
Kombination von einem Insulin und einem GLP-1-Agonisten
|
DE102008053048A1
(de)
|
2008-10-24 |
2010-04-29 |
Sanofi-Aventis Deutschland Gmbh |
Kombination von einem Insulin und einem GLP-1-Agonisten
|
DE102008064270A1
(de)
*
|
2008-12-20 |
2010-07-01 |
Voith Patent Gmbh |
Verfahren und Vorrichtung zur Flotation einer wässrigen Faserstoffsuspension
|
TW201105346A
(en)
*
|
2009-07-06 |
2011-02-16 |
Sanofi Aventis Deutschland |
Heat-stable and vibration-stable insulin preparations
|
MY159865A
(en)
|
2009-07-06 |
2017-02-15 |
Sanofi Aventis Deutschland |
Aqueous insulin preparations containing methionine
|
EP2451471A1
(de)
|
2009-07-06 |
2012-05-16 |
Sanofi-Aventis Deutschland GmbH |
Langsamwirkende insulinzubereitungen
|
WO2011012718A1
(en)
|
2009-07-31 |
2011-02-03 |
Ascendis Pharma As |
Prodrugs comprising an insulin linker conjugate
|
SG178195A1
(en)
|
2009-07-31 |
2012-03-29 |
Sanofi Aventis Deutschland |
Long acting insulin composition
|
JP5973918B2
(ja)
|
2009-11-13 |
2016-08-23 |
サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング |
Glp−1アゴニスト及びメチオニンを含む薬学的組成物
|
AU2010317995B2
(en)
|
2009-11-13 |
2014-04-17 |
Sanofi-Aventis Deutschland Gmbh |
Pharmaceutical composition comprising a GLP-1 agonist, an insulin, and methionine
|
EP2585484A1
(en)
*
|
2010-06-23 |
2013-05-01 |
Novo Nordisk A/S |
Insulin analogues containing additional disulfide bonds
|
CA2802510A1
(en)
*
|
2010-06-23 |
2011-12-29 |
Novo Nordisk A/S |
Insulin derivatives containing additional disulfide bonds
|
EP2585483A1
(en)
|
2010-06-23 |
2013-05-01 |
Novo Nordisk A/S |
Human insulin containing additional disulfide bonds
|
JP6199186B2
(ja)
|
2010-08-30 |
2017-09-20 |
サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング |
2型糖尿病の治療用の医薬の製造のためのave0010の使用
|
EP2438930A1
(en)
|
2010-09-17 |
2012-04-11 |
Sanofi-Aventis Deutschland GmbH |
Prodrugs comprising an exendin linker conjugate
|
WO2012123519A2
(en)
*
|
2011-03-15 |
2012-09-20 |
Novo Nordisk A/S |
Human insulin analogues and derivatives comprising cysteine substitutions
|
US9821032B2
(en)
|
2011-05-13 |
2017-11-21 |
Sanofi-Aventis Deutschland Gmbh |
Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
|
RU2650616C2
(ru)
|
2011-08-29 |
2018-04-16 |
Санофи-Авентис Дойчланд Гмбх |
Фармацевтическая комбинация для применения при гликемическом контроле у пациентов с сахарным диабетом 2 типа
|
TWI559929B
(en)
|
2011-09-01 |
2016-12-01 |
Sanofi Aventis Deutschland |
Pharmaceutical composition for use in the treatment of a neurodegenerative disease
|
MX2014012096A
(es)
|
2012-04-11 |
2014-11-21 |
Novo Nordisk As |
Formulaciones de insulina.
|
US20130315891A1
(en)
|
2012-05-25 |
2013-11-28 |
Matthew Charles |
Formulations of human tissue kallikrein-1 for parenteral delivery and related methods
|
LT2854841T
(lt)
|
2012-06-04 |
2017-06-12 |
Diamedica Inc. |
Kalikreino 1 iš žmogaus audinio glikozilinimo izoformos
|
US9707275B2
(en)
|
2012-12-19 |
2017-07-18 |
Wockhardt Limited |
Stable aqueous composition comprising human insulin or an analogue or derivative thereof
|
BR112015013223A2
(pt)
|
2012-12-26 |
2017-07-11 |
Wockhardt Ltd |
composição farmacêutica
|
TWI641381B
(zh)
|
2013-02-04 |
2018-11-21 |
法商賽諾菲公司 |
胰島素類似物及/或胰島素衍生物之穩定化醫藥調配物
|
JP2016531847A
(ja)
|
2013-09-30 |
2016-10-13 |
ウォックハート リミテッド |
医薬組成物
|
SI3055325T1
(en)
|
2013-10-07 |
2018-05-31 |
Novo Nordisk A/S |
NEW DERIVATIVE ANALOGUE INSULINE
|
MX2016008979A
(es)
|
2014-01-09 |
2016-10-04 |
Sanofi Sa |
Formulaciones farmaceuticas estabilizadas de analogos de insulina y/o derivados de insulina.
|
SG11201604706TA
(en)
|
2014-01-09 |
2016-07-28 |
Sanofi Sa |
Stabilized pharmaceutical formulations of insulin aspart
|
JP6723921B2
(ja)
|
2014-01-09 |
2020-07-15 |
サノフイSanofi |
インスリンアナログおよび/またはインスリン誘導体の、グリセリンを含まない安定化された医薬製剤
|
WO2016001862A1
(en)
|
2014-07-04 |
2016-01-07 |
Wockhardt Limited |
Extended release formulations of insulins
|
HRP20230470T1
(hr)
|
2014-12-12 |
2023-07-21 |
Sanofi-Aventis Deutschland Gmbh |
Formulacija fiksnog omjera inzulin glargin/liksisenatid
|
TWI748945B
(zh)
|
2015-03-13 |
2021-12-11 |
德商賽諾菲阿凡提斯德意志有限公司 |
第2型糖尿病病患治療
|
TW201705975A
(zh)
|
2015-03-18 |
2017-02-16 |
賽諾菲阿凡提斯德意志有限公司 |
第2型糖尿病病患之治療
|
TWI700091B
(zh)
|
2016-12-16 |
2020-08-01 |
丹麥商諾佛 儂迪克股份有限公司 |
含胰島素醫藥組成物
|
EP3592377A4
(en)
|
2017-03-09 |
2021-02-17 |
Diamedica Inc. |
DOSAGE FORMS OF TISSUE KALLIKREIN 1
|
EP3668892A1
(en)
|
2017-08-17 |
2020-06-24 |
Novo Nordisk A/S |
Novel acylated insulin analogues and uses thereof
|
CN109646396A
(zh)
*
|
2018-12-29 |
2019-04-19 |
江苏万邦医药科技有限公司 |
一种稳定的胰岛素类似物注射液及其制备方法
|